Search - tctmd.com

Displaying 921 - 940 of 1054

Sort: Relevancy | Date

News Conference News ACC 2015

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

Todd Neale

March 15, 2015

News Daily News

TRYTON Published: Noninferiority Not Shown for Dedicated Bifurcation Stent

Yael L. Maxwell

February 19, 2015

News Daily News

Arterial Thrombosis Common in Infants After Catheterization

February 17, 2015

News Daily News

Sex-Specific Biomarker Threshold Doubles MI Diagnosis in Women With Suspected ACS

January 29, 2015

News Daily News

‘Value’ of PCI Varies Widely Across VA Hospitals

Yael L. Maxwell

January 28, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Daily News

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Todd Neale

December 04, 2014

News Daily News

Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease

L.A. McKeown

November 20, 2014

News Daily News

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

November 17, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

L.A. McKeown

November 02, 2014

News Daily News

Substantial BP Reductions Appear to Lower Stroke Risk Safely in CAD Patients

Todd Neale

November 02, 2014

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

L.A. McKeown

October 10, 2014

News Daily News

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

L.A. McKeown

October 10, 2014

Presentation TCT 2014

Case #1: Targeting Massive Thrombus in Cardiogenic Shock

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, Goran K. Olivecrona

September 15, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

Advertisement

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

TRYTON Published: Noninferiority Not Shown for Dedicated Bifurcation Stent

Arterial Thrombosis Common in Infants After Catheterization

Sex-Specific Biomarker Threshold Doubles MI Diagnosis in Women With Suspected ACS

‘Value’ of PCI Varies Widely Across VA Hospitals

TCTMD’s Top 10 Most Popular News Stories for 2014

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

Substantial BP Reductions Appear to Lower Stroke Risk Safely in CAD Patients

Acute Hyperglycemia Worsens Post-AMI Prognosis

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

Case #1: Targeting Massive Thrombus in Cardiogenic Shock

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content